These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
274 related articles for article (PubMed ID: 29852774)
21. Genomic profile of human meningioma cell lines. Mei Y; Bi WL; Greenwald NF; Agar NY; Beroukhim R; Dunn GP; Dunn IF PLoS One; 2017; 12(5):e0178322. PubMed ID: 28552950 [TBL] [Abstract][Full Text] [Related]
22. YAP1-FAM118B Fusion Defines a Rare Subset of Childhood and Young Adulthood Meningiomas. Schieffer KM; Agarwal V; LaHaye S; Miller KE; Koboldt DC; Lichtenberg T; Leraas K; Brennan P; Kelly BJ; Crist E; Rusin J; Finlay JL; Osorio DS; Sribnick EA; Leonard JR; Feldman A; Orr BA; Serrano J; Vasudevaraja V; Snuderl M; White P; Magrini V; Wilson RK; Mardis ER; Boué DR; Cottrell CE Am J Surg Pathol; 2021 Mar; 45(3):329-340. PubMed ID: 33074854 [TBL] [Abstract][Full Text] [Related]
23. Prognostic impact of genetic alterations and methylation classes in meningioma. Berghoff AS; Hielscher T; Ricken G; Furtner J; Schrimpf D; Widhalm G; Rajky U; Marosi C; Hainfellner JA; von Deimling A; Sahm F; Preusser M Brain Pathol; 2022 Mar; 32(2):e12970. PubMed ID: 35213082 [TBL] [Abstract][Full Text] [Related]
24. Genomic Landscape of Meningiomas. Wang JZ; Nassiri F; Mawrin C; Zadeh G Adv Exp Med Biol; 2023; 1416():137-158. PubMed ID: 37432625 [TBL] [Abstract][Full Text] [Related]
25. Molecular alterations in meningioma: prognostic and therapeutic perspectives. Birzu C; Peyre M; Sahm F Curr Opin Oncol; 2020 Nov; 32(6):613-622. PubMed ID: 32890025 [TBL] [Abstract][Full Text] [Related]
26. Meningioma: current updates on genetics, classification, and mouse modeling. Szulzewsky F; Thirimanne HN; Holland EC Ups J Med Sci; 2024; 129():. PubMed ID: 38571886 [TBL] [Abstract][Full Text] [Related]
27. Genomic analysis of synchronous intracranial meningiomas with different histological grades. Chowdhury T; Yoo Y; Seo Y; Dho YS; Kim S; Choi A; Choi M; Park SH; Park CK; Lee SH; Lee JY J Neurooncol; 2018 May; 138(1):41-48. PubMed ID: 29423538 [TBL] [Abstract][Full Text] [Related]
28. Associations of pathological diagnosis and genetic abnormalities in meningiomas with the embryological origins of the meninges. Okano A; Miyawaki S; Hongo H; Dofuku S; Teranishi Y; Mitsui J; Tanaka M; Shin M; Nakatomi H; Saito N Sci Rep; 2021 Mar; 11(1):6987. PubMed ID: 33772057 [TBL] [Abstract][Full Text] [Related]
29. Meningioma: Molecular Updates from the 2021 World Health Organization Classification of CNS Tumors and Imaging Correlates. Soni N; Ora M; Bathla G; Szekeres D; Desai A; Pillai JJ; Agarwal A AJNR Am J Neuroradiol; 2024 Oct; ():. PubMed ID: 38844366 [TBL] [Abstract][Full Text] [Related]
30. Analysis of the results of recurrent intracranial meningiomas treated with re-radiosurgery. Kim M; Lee DH; Kim Rn HJ; Cho YH; Kim JH; Kwon DH Clin Neurol Neurosurg; 2017 Feb; 153():93-101. PubMed ID: 28081463 [TBL] [Abstract][Full Text] [Related]
31. Advances in Molecular Classification and Therapeutic Opportunities in Meningiomas. Cordova C; Kurz SC Curr Oncol Rep; 2020 Jul; 22(8):84. PubMed ID: 32617743 [TBL] [Abstract][Full Text] [Related]
32. Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations. Brastianos PK; Horowitz PM; Santagata S; Jones RT; McKenna A; Getz G; Ligon KL; Palescandolo E; Van Hummelen P; Ducar MD; Raza A; Sunkavalli A; Macconaill LE; Stemmer-Rachamimov AO; Louis DN; Hahn WC; Dunn IF; Beroukhim R Nat Genet; 2013 Mar; 45(3):285-9. PubMed ID: 23334667 [TBL] [Abstract][Full Text] [Related]
33. A new amplicon-based gene panel for next generation sequencing characterization of meningiomas. Mawrin C; Koch R; Waldt N; Sandalcioglu IE; Braunsdorf WEK; Warnke JP; Goehre F; Meisel HJ; Ewald C; Neyazi S; Schüller U; Kirches E Brain Pathol; 2022 Mar; 32(2):e13046. PubMed ID: 35213080 [TBL] [Abstract][Full Text] [Related]
34. Genomic landscape of intracranial meningiomas. Bi WL; Abedalthagafi M; Horowitz P; Agarwalla PK; Mei Y; Aizer AA; Brewster R; Dunn GP; Al-Mefty O; Alexander BM; Santagata S; Beroukhim R; Dunn IF J Neurosurg; 2016 Sep; 125(3):525-35. PubMed ID: 26771848 [TBL] [Abstract][Full Text] [Related]
35. Meningioma progression in mice triggered by Nf2 and Cdkn2ab inactivation. Peyre M; Stemmer-Rachamimov A; Clermont-Taranchon E; Quentin S; El-Taraya N; Walczak C; Volk A; Niwa-Kawakita M; Karboul N; Giovannini M; Kalamarides M Oncogene; 2013 Sep; 32(36):4264-72. PubMed ID: 23045274 [TBL] [Abstract][Full Text] [Related]
36. Molecular genetics of meningiomas: Building the roadmap towards personalized therapy. Peyre M; Kalamarides M Neurochirurgie; 2018 Mar; 64(1):22-28. PubMed ID: 25245924 [TBL] [Abstract][Full Text] [Related]
37. Genomic analysis of spinal meningiomas: correlation with histopathological grade. Driver J; Santagata S; Bi WL; Chi JH J Neurosurg Spine; 2023 Dec; 39(6):729-733. PubMed ID: 37728381 [TBL] [Abstract][Full Text] [Related]
38. [Meningioma]. Sasaki H No Shinkei Geka; 2023 Sep; 51(5):829-836. PubMed ID: 37743334 [TBL] [Abstract][Full Text] [Related]
39. Variations in the genomic profiles and clinical behavior of meningioma by racial and ethnic group. Tabor JK; Dincer A; O'Brien J; Lei H; Vetsa S; Vasandani S; Jalal MI; Yalcin K; Morales-Valero SF; Marianayagam N; Alanya H; Elsamadicy AA; Millares Chavez MA; Aguilera SM; Mishra-Gorur K; McGuone D; Fulbright RK; Jin L; Erson-Omay EZ; Günel M; Moliterno J J Neurosurg; 2024 Sep; 141(3):664-672. PubMed ID: 38518289 [TBL] [Abstract][Full Text] [Related]